MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Segmentation of neck muscles using ultrasound in cervical dystonia

    A. Siddique, R. Cunningham, M. Silverdale, P. Harding, I. Loram, C. Kobylecki (Salford, United Kingdom)

    Objective: Identify neck muscle boundaries using real-time ultrasound in cervical dystonia and relate imaging data to neck muscle structure and function. Background: Identification of individual…
  • 2018 International Congress

    Duration of response with abobotulinumtoxinA in cervical dystonia: Patient distribution results from two open label extension studies

    R. Hauser, D. Truong, M. Jog, D. Grimes, P. Picaut, A. Mann (Tampa, FL, USA)

    Objective: To report patient distribution data for duration of response with abobotulinumtoxinA (aboBoNT-A; Dysport®) from two open-label (OL) studies in patients with cervical dystonia (CD).…
  • 2018 International Congress

    Physiological effects of Botulinum Toxin therapy in Primary Cervical Dystonia

    W. Deeb, W. Hu, A. Wagle Shukla (Gainesville, FL, USA)

    Objective: To examine the physiological effects of botulinum toxin (BoNT) therapy, as measured by paired-pulse transcranial magnetic stimulation (TMS), in patients with primary cervical dystonia…
  • 2018 International Congress

    Abnormal cerebellar learning in cervical dystonia

    T. Bäumer, E. Tzvi, J. Junker, J. Verrel, S. Loens (Luebeck, Germany)

    Objective: This study was conceptualized to asses if patients with cervical dystonia (CD) exhibit deficits in cerebellar function tested by motor adaptation and motor sequence…
  • 2018 International Congress

    Neuropathology of dopa-responsive dystonia due to Tyrosine hydroxylase deficiency

    S. Schreglmann, Z. Jaunmuktane, H. Jung, C. Strand, J. Holton, K. Bhatia (London, United Kingdom)

    Objective: To describe detailed neuropathology findings from an autopsy case of dopa-responsive dystonia (DRD) with genetically confirmed tyrosine hydroxylase deficiency (THD). Background: DRD comprises a…
  • 2018 International Congress

    Underserved Patient Access to Movement Disorders Care: Experience from a Tertiary Academic Referral Center

    A. Giacobbe, E. Dinh, O. Nguyen, A. Ramirez-Zamora, M. Okun, L. Almeida (Gainesville, FL, USA)

    Objective: To explore geographical and clinic-demographical profile of underserved patients in Florida diagnosed with movement disorders. Background: Movement disorders are complex conditions that often require…
  • 2018 International Congress

    Prediction of suicidality in Huntington disease: Analysis of Enroll-HD data using machine learning approach

    Y. Seliverstov, A. Borzov, E. van Duijn, B. Landwehrmeyer, M. Belyaev (Moscow, Russian Federation)

    Objective: To develop a model for prediction of suicidal ideation or suicidal behaviour in Huntington disease gene expansion carriers (HDGEC) based on Enroll-HD data using…
  • 2018 International Congress

    Comparing risperidone and olanzapine to tetrabenazine for the management of Huntington’s chorea

    J. Schultz, J. Kamholz, P. Nopoulos, A. Killoran (Iowa City, IA, USA)

    Objective: To compare the efficacy of risperidone and olanzapine to tetrabenazine (TBZ) for the management of Huntington’s chorea in Enroll-HD participants. Background: TBZ is provenly-effective…
  • 2018 International Congress

    Submandibular gland is a suitable tissue for alpha synuclein pathology in Parkinson’s disease

    JH. Shin, SH. Park, CW. Shin, JH. Kim, TJ. Yun, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: To validate the role of α-synuclein (AS) pathology in submandibular gland (SMG) as a biomarker for Parkinson disease (PD). Background: The pathologic hallmark of…
  • 2018 International Congress

    STN-DBS responsive motor complication and pathological gambling in type IV SCA3

    M. Kuo, C. Tai, R. Wu (New Taipei, Taiwan)

    Objective: Background: Type IV spinocerebellar ataxia type 3 (SCA3) could present as pure parkinsonism. A bilateral subthalamic nucleus deep brain stimulation (STN-DBS) has been reported…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley